Dr. Ángel Raya’s group receives funding from La Marató 3Cat dedicated to cardiovascular diseases

November 9, 2023

Stem Cell Potency group, lead by Dr. Ángel Raya at the P-CMR[C] and IDIBELL, together with three other research teams from IDIBELL, have been awarded by La Marató 3Cat Foundation, which, yesterday afternoon announced the projects that will receive funding from the La Marató 2022 edition. The awarded research groups will work over the next 3 years to find answers in the field of cardiovascular health. Heart and circulatory system diseases have a high impact on people’s quality and life expectancy: they are the main cause of death and hospital admission in developed countries. In Catalonia, 45 people die every day, two every hour, due to a health problem of this type.

The IDIBELL principal investigators who will be able to start their new research projects thanks to this solidarity program are: Dr. Ángel Raya Chamorro, also PCMR-C co-director, who is going to analyze the clinical translation of iPSC-based cell therapies for heart failure; Dr. Ignasi Anguera Camos, who will carry out a clinical trial to prevent cardiomyopathy; Dr. Cristina Enjuanes Grau, who will lead a cardiac rehabilitation project focused on coronary heart disease patients; and Dr. José López López, who will study periodontal disease and hypertension. Dr. Raya will work in collaboration with Dr. Sergi Querol Giner (Banc de Sang i Teixits) and Dr. Francisco Miguel Sánchez Margallo (Fundación Centro de Cirugía de Mínima Invasión Jesús Usón, Càceres).

The 2022 edition of La Marató raised a total of 11.2 million euros, which will allow 71 research teams to carry out 37 projects in cardiovascular health to move forward in the prevention, diagnosis and treatment of such diseases, which are the leading cause of death in developed countries. In 31 years of experience, La Marató has financed a total of 1,022 research projects.